| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Monoclonal Antibodies, Office of Biotechnology Products, Office of Pharmaceutical Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, MD 20892
Anthrax lethal toxin (LT) is a critical virulence factor that cleaves and inactivates MAPK kinases (MAPKKs) in host cells and has been proposed as a therapeutic target in the treatment of human anthrax infections. Despite the potential use of anti-toxin agents in humans, the standard activity assays for anthrax LT are currently based on cytotoxic actions of anthrax LT that are cell-, strain-, and species-specific, which have not been demonstrated to occur in human cells. We now report that T cell proliferation and IL-2 production inversely correlate with anthrax LT levels in human cell assays. The model CD4+ T cell tumor line, Jurkat, is a susceptible target for the specific protease action of anthrax LT. Anthrax LT cleaves and inactivates MAPKKs in Jurkat cells, whereas not affecting proximal or parallel TCR signal transduction pathways. Moreover, anthrax LT specifically inhibits PMA/ionomycin- and anti-CD3-induced IL-2 production in Jurkat cells. An inhibitor of the protease activity of anthrax LT completely restores IL-2 production by anthrax LT-treated Jurkat cells. Anthrax LT acts on primary CD4+ T cells as well, cleaving MAPKKs and leading to a 95% reduction in anti-CD3-induced proliferation and IL-2 production. These findings not only will be useful in the development of new human cell-based bioassays for the activity of anthrax LT, but they also suggest new mechanisms that facilitate immune evasion by Bacillus anthracis. Specifically, anthrax LT inhibits IL-2 production and proliferative responses in CD4+ T cells, thereby blocking functions that are pivotal in the regulation of immune responses.
This article has been cited by other articles:
|
|
 |
|
  R. N. Mahon, R. E. Rojas, S. A. Fulton, J. L. Franko, C. V. Harding, and W. H. Boom Mycobacterium tuberculosis Cell Wall Glycolipids Directly Inhibit CD4+ T-Cell Activation by Interfering with Proximal T-Cell-Receptor Signaling Infect. Immun., October 1, 2009; 77(10): 4574 - 4583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Warfel and F. D'Agnillo Anthrax Lethal Toxin Enhances I{kappa}B Kinase Activation and Differentially Regulates Pro-inflammatory Genes in Human Endothelium J. Biol. Chem., September 18, 2009; 284(38): 25761 - 25771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, P. F. Barnes, K. M. Dobos-Elder, J. C. Townsend, Y.-t. Chung, H. Shams, S. E. Weis, and B. Samten ESAT-6 Inhibits Production of IFN-{gamma} by Mycobacterium tuberculosis-Responsive Human T Cells J. Immunol., March 15, 2009; 182(6): 3668 - 3677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xu, H. Fang, and D. M. Frucht Anthrax Lethal Toxin Increases Superoxide Production in Murine Neutrophils via Differential Effects on MAPK Signaling Pathways J. Immunol., March 15, 2008; 180(6): 4139 - 4147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-D. Ha, D. Ng, S. L. Pelech, and S. O. Kim Critical Role of the Phosphatidylinositol 3-Kinase/Akt/Glycogen Synthase Kinase-3 Signaling Pathway in Recovery from Anthrax Lethal Toxin-induced Cell Cycle Arrest and MEK Cleavage in Macrophages J. Biol. Chem., December 14, 2007; 282(50): 36230 - 36239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. J. Glomski, J.-P. Corre, M. Mock, and P. L. Goossens Cutting Edge: IFN-{gamma}-Producing CD4 T Lymphocytes Mediate Spore-Induced Immunity to Capsulated Bacillus anthracis J. Immunol., March 1, 2007; 178(5): 2646 - 2650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sherer, Y. Li, X. Cui, and P. Q. Eichacker Lethal and Edema Toxins in the Pathogenesis of Bacillus anthracis Septic Shock: Implications for Therapy Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 211 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Crawford, C. V. Aylott, R. W. Bourdeau, and G. M. Bokoch Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity. J. Immunol., June 15, 2006; 176(12): 7557 - 7565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fang, L. Xu, T. Y. Chen, J. M. Cyr, and D. M. Frucht Anthrax Lethal Toxin Has Direct and Potent Inhibitory Effects on B Cell Proliferation and Immunoglobulin Production J. Immunol., May 15, 2006; 176(10): 6155 - 6161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Comer, A. K. Chopra, J. W. Peterson, and R. Konig Direct Inhibition of T-Lymphocyte Activation by Anthrax Toxins In Vivo Infect. Immun., December 1, 2005; 73(12): 8275 - 8281. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
